Blog

Six Major Banks Successfully Trialed Fragmos Chain Platform, Initiating Automation for Uncleared OTC Derivatives, Setting the Stage to Tackle 66% of Operational Costs & Risks in a $250 Trillion Market

Fragmos Chain, an innovative fintech company, is thrilled to announce the resounding success of its recent platform trial, conducted in partnership with a consortium of six leading investment banks across Europe, Asia, and North America. The trial, which took place in February and March 2024, marked a significant milestone in the evolution of post-trade processing …

Six Major Banks Successfully Trialed Fragmos Chain Platform, Initiating Automation for Uncleared OTC Derivatives, Setting the Stage to Tackle 66% of Operational Costs & Risks in a $250 Trillion Market Read More »

Initiation of a Collective Action involving over 10 leading Investment Banks

Fragmos Chain has initiated a collective trial involving over 10 leading investment banks, collectively representing a 30% market share among broker-dealers. The focus of this trial is the transformation of OTC derivatives processing. During a meeting sponsored by a major Investment Bank, these banks have acknowledged the increased efficiency, reduced risks, and substantial cost savings …

Initiation of a Collective Action involving over 10 leading Investment Banks Read More »

Achieving full compliance with EMIR

More than 10 years after the publication of EMIR, the EU regulation on OTC derivatives, financial institutions continue to face significant challenges in achieving full compliance with its extensive requirements: ·       Despite the requirement in article 11.1 of EMIR to perform confirmations for uncleared derivatives through “electronic means”, approximately 50% of these confirmations …

Achieving full compliance with EMIR Read More »

Risks on OTC derivatives: which asset classes?

Uncleared OTC derivatives pose a significant risk to capital markets, as they can result in substantial financial losses due to fraud, operational errors, and non-compliance with regulations. But which asset classes are we talking about here? Our research on Investment Banks reveals that most types of asset classes are impacted, but for different reasons: Equity …

Risks on OTC derivatives: which asset classes? Read More »

Reduce risks on OTC derivatives with Fragmos Chain’s CDM-native platform

Uncleared OTC derivatives carry a disproportionate amount of risk in capital markets, leading to significant financial losses due to fraud, operational errors, and non-compliance with regulations. At Fragmos Chain, we have developed a platform that combines CDM (Common Domain Model) and Corda DLT (Distributed Ledger Technology) to automate post-trade processes and create a shared and …

Reduce risks on OTC derivatives with Fragmos Chain’s CDM-native platform Read More »

Finastra onboards Fragmos Chain’s blockchain platform for the digitalization of over-the-counter derivatives post-trade

London, UK – November 22, 2022 – Today Finastra announced a collaboration with Fragmos Chain, a blockchain platform which digitalizes interactions between financial institutions, to provide Finastra customers with out-of-the-box integration with Finastra Summit, its over-the-counter (OTC) derivatives market solution. The API-first integration, via FusionFabric.cloud, enables banks globally to digitalize their OTC derivatives products to reduce the costs and risks …

Finastra onboards Fragmos Chain’s blockchain platform for the digitalization of over-the-counter derivatives post-trade Read More »

The scope of Fragmos Chain post-trade platform for OTC derivatives is extending

① To manage any kind of swap and any kind of event, we recently added 3 functionalities: Matching of events and cash-flows Complex features such as risk-free rates, cap/floors or non-deliverable currencies Basket underliers As the only ISDA CDM-native post-trade platform, we capitalize on CDM’s modularity to offer a broad variety of products. We are …

The scope of Fragmos Chain post-trade platform for OTC derivatives is extending Read More »

Upcoming regulatory requirements pave the way for global OTC overhaul

While new regulatory requirements enter into force in the coming months, ISDA Chief Executive Officer Scott O’Malia’s recent announcement shows that its Common Domain Model (CDM) is becoming central for financial firms in order to meet these requirements1. We believe this is just the prelude to an extensive overhaul of the management of OTC trades, …

Upcoming regulatory requirements pave the way for global OTC overhaul Read More »

Fragmos Chain at CordaCon 2021

Why OTC Derivatives? Our CEO, Daniel Ivanier, was invited by R3 to talk at the CordaCon 2021. Key highlights: Post-trade costs are huge for OTC derivatives: $400 per trade (compared to $2 for listed derivatives) Processes are complex These products are heavily regulated